Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,900.00
+21.20 (1.13%)
Jul 31, 2026, 3:29 PM IST
Dr. Lal PathLabs Stock Forecast
Stock Price Forecast
According to 26 analysts polled by S&P Global, Dr. Lal PathLabs stock has a consensus rating of "Buy" and an average price target of ₹1,920. The average 1-year stock price forecast is 1.06% higher than the current stock price, while the lowest is ₹1,180 (-37.89%) and the highest is ₹2,195 (+15.53%).
Price Target: ₹1,920 (+1.06%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Feb 17, 2026.
Analyst Ratings
The average analyst rating for Dr. Lal PathLabs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 13 | 17 | 17 | 17 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 3 | 2 | 1 | 1 | 1 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 4 | 2 | 2 | 2 | 2 | 2 |
| Total | 25 | 25 | 24 | 26 | 26 | 26 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Geojit Research No rating | Geojit Research | Hold Maintains ₹1,577 | Hold | Maintains | ₹1,577 | -17.00% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
32.00B
from 27.63B
Increased by 15.83%
Revenue Next Year
36.36B
from 32.00B
Increased by 13.62%
EPS This Year
37.31
from 30.40
Increased by 22.71%
EPS Next Year
43.37
from 37.31
Increased by 16.26%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.